Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) (Q29620605)
scientific article published in The Lancet
Language:
Current Data About Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
(P31) (Q13442814)

(P304) 1527-37
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

(P407) (Q1860)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

(P433) 9496
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

(P478) 366
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

(P921) (Q181600)
(P887)

(Q269829)
(P887)

(Q47912)
(P887)

(P1433) (Q939416)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

(P1476) "Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)" (language: en)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

(P2093) Thatcher N
(P1545) 1
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Chang A
(P1545) 2
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Parikh P
(P1545) 3
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Rodrigues Pereira J
(P1545) 4
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Ciuleanu T
(P1545) 5
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

von Pawel J
(P1545) 6
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Thongprasert S
(P1545) 7
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Tan EH
(P1545) 8
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Pemberton K
(P1545) 9
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Archer V
(P1545) 10
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

Carroll K
(P1545) 11
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16257339
(P813) Sunday, April 30, 2017

(P2860) (Q27860562)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q43658480)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q33345025)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q29615476)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q53521886)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q35033439)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34271566)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34533636)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34546316)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q40489484)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q29396936)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q27860904)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q53450591)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q29547546)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34528550)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q44135091)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q44471337)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34522758)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34417512)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q27861059)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q27824812)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34559274)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q29615475)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q24561953)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34555510)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q34557318)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

(Q35956595)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967625-8
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published in The Lancet

External Links
(P356) 10.1016/S0140-6736(05)67625-8
(P698) 16257339
(P3181) 331396